BDSX

Biodesix Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 5/10
  • Momentum 8/10
Biodesix sales and earnings growth
BDSX Growth
Neutral
  • Revenue Y/Y 22.29%
  • EPS Y/Y 29.47%
  • FCF Y/Y 52.99%
Biodesix gross and profit margin trends
BDSX Profitability
Neutral
  • Gross margin 79.80%
  • EPS margin -49.30%
  • ROIC -31.60%
Biodesix net debt vs free cash flow
BDSX Risk
Great
  • Debt / Equity -42.4
  • Debt / FCF 1.9
  • Interest coverage -4.3

Biodesix stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Diagnostics & Research stocks ↗